This research underscores the necessity for comprehensive genetic screening in patients with complex Rubinstein–Taybi syndrome (RSTS) phenotypes, potentially uncovering novel variants in CREBBP and EP300. Here, EP300 is linked to Rubinstein-Taybi syndrome due to CREBBP mutations.